Feature | Cath Lab | October 27, 2016| Dave Fornell

What You Need to Know to Prepare for TCT 2016

Videos, news and articles regarding the hottest topics and data presentations at the 2016 Transcatheter Cardiovascular Therapeutics annual meeting

Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics

The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional cardiology conference can be overwhelming. So, to prepare for the meeting, here is a list of some key items that will be covered in sessions, live cases and late-breaking trial presentations. It includes videos, articles, news and U.S. Food and Drug Administration (FDA) clearances that will be among the hottest topics at this year’s TCT, in Washington, D.C., Oct. 30 - Nov. 2. 

TCT Announces Late-breaking Trials and First Reports

FDA Approves First Totally Bioresorbable Stent

VIDEO: Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries - Discussion with Gregg Stone

VIDEO: TAVR Beats Surgery — Top News From ACC.16 - Discussion With Vinod Thourani

FDA Clears Lithoplasty Balloon That Shatters Calcified Lesions With Ultrasound

Understanding the Design and Function of Guidewire Technology - Interview With Dimitri Karmpaliotis

VIDEO: Transcatheter Structural Heart Procedure Navigation Technology Advances - Discussion with Stephen Little

Role of Imaging in Bioresorbable Stent Procedures

VIDEO: Post-FDA Approval Experience of LAA Occluders - Discussion With David Holmes

10 Reasons Why You Need Supplemental Imaging in the Cath Lab

VIDEO: Key Bioresorbable Stent Technology Presented at TCT 2015 - Discussion With Dean Kereiakes

Osprey Receives $28 Million in Funding for its Cath Lab Contrast Reduction Technology

Advances and Future Directions for Transcatheter Valves (Includes several VIDEO links)

VIDEO: Impact of TAVR Procedural Volume on Patient Outcomes - Discussion With John Carroll

FDA Expands Sapien TAVR Valve Indication to Intermediate-Risk Patients

VIDEO: What to Look for in CT Structural Heart Planning Software - Discussion With Jonathan Leipsic

VIDEO: Declining TAVR Stroke Rates in Key Trials Presented at ACC.16 - Discussion With Chandan Devireddy

Robotics May Aid Implantation of Bioresorbable Stents

VIDEO: Editor's Choice of the Most Innovative New Interventional Cardiology Technologies at TCT 2015

VIDEO: What is Required for Interventional Echo - Discussion With Rebecca Hahn

Two-Year Xeltis Bioabsorbable Valve Data Shows Positive Functionality

VIDEO: State of Therapy for Critical Limb Ischemia - Discussion With Michael Jaff

Update on Atherectomy System Technology

VIDEO: Drug-Filled Stents as an Alternative to Polymer Drug Carriers - Discussion With Stephen Worthley

5 Technologies to Reduce Cath Lab Radiation Exposure

VIDEO: New Technology Trends at TCT 2015

Questions Remain on Future of Bioresorbable Stents

VIDEO: Trends in Cardiac Technology on the Show Floor at ACC.16

Questions Remain on DAPT Prolongation

VIDEO: Demonstration of a Transcatheter PFO Occluder Implantation

Study Shows New Brain Lesions in 94 Percent of Patients Following TAVR

VIDEO: Update on U.S. Transradial Access Adoption - Discussion With Sunil Rao

Moderate Sedation Shows Promise for TAVR Patients

VIDEO: Advances in Interventional Heart Failure Hemodynamic Support at TCT 2015 - Discussion With Manesh Patel

Interventional X-ray Advancements in Imaging

Medtronic IN.PACT Admiral Drug-Coated Balloon Approved for Treatment of In-stent Restenosis

Reducing Heart Failure Readmissions

New Technologies to Treat Peripheral Artery Disease (PAD)

Related Content

Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020

Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip was the subject of two studies, including use to aid heart transplant patients. Bottom right, the Boston Scientific Acurate neo TAVR valve performed below the Sapien 3 and CoreValve Evolut.

Feature | TCT | October 29, 2020 | Dave Fornell, Editor
Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials prese
TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT
Feature | TCT | October 29, 2020
October 29, 2020 — The late-breaking studies are one of the hallmarks of the annual...
Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

News | TCT | October 14, 2020
October 14, 2020 — The American College of Cardiology (ACC) and the...
Videos | TCT | August 01, 2020
With COVID-19 forcing all medical conferences to go virtual in 2020,...
EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment for structural heart procedures. #TCT2019 #TCT #TCT19

EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment in structural heart procedures. (Photos by Dave Fornell)

Feature | TCT | November 04, 2019 | Dave Fornell, Editor
The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual ...
TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019
Feature | TCT | October 11, 2019
The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 late-breaking science...
Videos | TCT | October 03, 2018
DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the ex
cardiologist Ted Feldman, M.D., at TCT 2017. #TCT2018 #TCT #TCT18 TCT Late breaking trials, studies.
Feature | TCT | September 21, 2018
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking clini
Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics. #TCT #TCT18 #TCT2018
Feature | TCT | September 14, 2018 | Dave Fornell, Editor
The volume of information attendees receive at the annual...